Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, September 18, 2014
 
Register | Sign in
Home Page>Products
  Product News
Malvern Explores Rheology for Protein Formulation at 2nd Protein-Protein Interaction Conference
Thursday, September 18, 2014
Malvern Instruments will contribute a scientific poster at the 2014 Protein-Protein Interaction Conference, October 23-24, Boston, MA, USA.

Phenomenex Expands its Aeris® PEPTIDE Core-Shell Column Line
Thursday, September 18, 2014
The line now includes a 5 µm particle size for small-scale purifications.

Enhance Sample Preconcentration and Reduce Workflow
Thursday, September 18, 2014
New method developed by Thermo Fisher Scientific using solid-phase extraction well plates.

Respected Synthetic Biology Group Chooses G:BOXChemi XT4
Wednesday, September 17, 2014
To speed up analysis of DNA and proteins from bacteria engineered to process heavy metals accumulated in plants grown on contaminated soil.

New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph from Shimadzu
Wednesday, September 17, 2014
The system empowers laboratories to separate even the most complex mixtures.

Complete, Automated ASTM D2983 Sample Conditioning and Testing
Tuesday, September 16, 2014
The first fully automated Thermoelectric Sample Conditioner (TESC) System from CANNON.

Global OEM Strategy with a Wealth of Expertise and Experience
Tuesday, September 16, 2014
Company will be participating in the CPhl Worldwide pharmaceutical trade fair in Paris.

Delenex Therapeutics AG Expands Pipeline
Tuesday, September 16, 2014
Extremely high potency and small size uniquely position products in dermatological and inflammatory diseases.

Designed Especially For The Phenom Desktop SEM: PoroMetric Software for Fully Automated Measurement and Analysis of Pores
Tuesday, September 16, 2014
The combination of speed, ease of use and superb imaging quality of the Phenom and image pore analysis software of PoroMetric creates a powerful tool for inspecting wide range of samples like filters and membranes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv